Vaccine Platform Equipment & Supplies
13 equipment items found
Manufactured by:Lipotek based inActon, AUSTRALIA
Lipovax-Fg115 is an adjuvanted delivery vehicle for recombinant antigens. The platform exploits the commonly used his-tag to attach multiple copies of one or more type of antigens to the surface Lipovax-Fg115 particles. Our proprietary Fg115 molecules are also attached to the liposomes to stimulate the TLR5 receptor. The platform improves vaccine ...
Manufactured by:FluGen, Inc. based inMadison, WISCONSIN (USA)
The M2 Deleted Single Replication Live Virus Vaccine (M2SR) offers a potentially differentiating clinical value proposition. FluGen’s flu vaccine candidate works differently, stimulating mucosal, humoral, and cellular immunity, and offering unprecedented efficacy against infection and illness across seven years of virus drift, and documented steady immune response for at least six ...
Manufactured by:Ziphius Vaccines NV based inMerelbeke, BELGIUM
Self-amplifying RNA (saRNA) or replicon RNA has the advantage of having self-replicating features, as the saRNA molecule encodes a viral RNA replicase in addition to the sequence of the protein(s) of interest. Upon cytoplasmic delivery of the saRNA molecule, the viral replicase is translated and generates multiple copies of the original saRNA strands. Consequently, a significantly high amount of ...
Manufactured by:B Medical Systems based inHosingen, LUXEMBOURG
Vaccine Refrigerator & Ice-pack Freezer: Set Temperature: +5°C (R) | -20°C (F). Vaccine storage capacity: 60 L. Ice-pack storage (at 0.6 L): 20. Certifications: EMC directive 2014/30/EC | Low voltage 2014/35/EUC. Freeze protection: Grade A. Climate class (ambient temperature range): Hot zone (+43°C). Energy source: ...
Manufactured by:Abera Bioscience AB based inUppsala, SWEDEN
Abera’s proprietary vaccine delivery platform – BERA, enables high-level multivalent presentation of recombinant antigens on bacterial Outer Membrane Vesicles (OMVs) for strong stimulation of the immune ...
Manufactured by:Ziphius Vaccines NV based inMerelbeke, BELGIUM
Proteins are large biological macromolecules that are essential parts of organisms and participate in virtually every process within cells. Proteins are created through the process of gene expression, in which genetic information from DNA is transcribed into messenger RNA (mRNA) in the cell nucleus. Next, the mRNA gets translated by ribosome in the cytoplasm into functional proteins. RNAs are ...
Manufactured by:Angany Inc. based inSt-Jean, QUEBEC (CANADA)
ANGANY is joining the COVID-19 effort with its promising novel vaccination technology. The unprecedented social and economic upset caused by the pandemic called for social responsibility. ANGANY’s entire team pitched in to join the fight! The fight against allergy is at the heart of ANGANY’s mission. And it is to overcome the specific challenges of allergy that ANGANY has developed a ...
Manufactured by:Akshaya Bio Inc. based inEdmonton, ALBERTA (CANADA)
The Chimigen® Platform is a flexible platform vaccine technology designed to elicit both humoral and cellular immune responses in ...
Manufactured by:CDBioSciences - VLPlant based inShirley, NEW YORK (USA)
VLPlant can synthesize expression vectors according to target genes provided by customers, and of course we can screen target genes for you. The vector containing the gene of interest is transformed into plant cells infiltrated in a transient expression system (mediated byAgrobacterium) to produce VLPs. Once plant growth is complete, we harvest the plant cells, isolate and purify the VLPs, and ...
by:Evaxion Biotech A/S based inHørsholm, DENMARK
EDEN is our second AI platform that rapidly identifies novel, highly protective antigens for the use in pathogen-specific prophylactic vaccines against bacteria. EDEN has been designed to rapidly identify those antigens that will trigger a robust protective immune response against almost any bacterial infectious disease. In addition, EDEN redesigns identified ...
Manufactured by:Ardigen based inKraków, POLAND
Quick solution for effective immune responses in clinical trials; We have created an Artificial Intelligence platform dedicated to being a part of the therapeutic cancer vaccine development. The ArdImmune Vax platform uses sequencing data to generate and prioritize antigen targets for cancer vaccines and T-cell ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-1850 is the planned new version of the TNX-1800 vaccine that encodes spike protein from SARS-CoV-2 BA.2 ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals and ethnicities. PolyPEPI-SCoV-2 vaccine can elicit broad and long-lasting immune responses in vaccinated subjects and can therefore protect people ...